November 11-13, 2013 • China National Convention Center, Beijing, China

China’s Innovation Gets a Global Look.

Visit bio.org/biochina (ENG) or biochina2013.com (CN) for more information.

The 3rd annual BIO Convention in China builds on the success of the BIO International Convention, the world’s largest biotechnology event. The BIO Convention in China brings together biotechnology, pharmaceutical and investment executives from around the globe to meet and explore business opportunities in China’s biopharma sector.  

In 2013, we anticipate:• 1,000 attendees • 400 companies • 100 exhibitors • 40 company presentations

Conference Features1. Keynotes by Government Officials and Business Leaders*

• Chen Zhu, Vice-Chairman, National People’s Congress, People’s Republic of China • Yin Li, Vice Minister of China Food and Drug Administration (CFDA) • Gary Locke, U.S. Ambassador to China • Brook Byers, Partner, Kleiner Perkins Caufield & Byers • Robert Nelsen, Co-Founder and Managing Director, ARCH Venture Partners

2. Private Business Development & Partnering Meetings Prior to the conference, pre-scheduled meetings are arranged via BIO One-on-One PartneringTM, a web-based platform that enables participants to move efficiently from the identification of prospective partners to discussion and negotiations.

3. Company Presentations Senior executives from Chinese and Western companies will discuss their technologies and interests in developing collaborations and strategic alliances.

4. Plenary Sessions & Business Roundtables China-specific and Western-focused programming sessions are led by key business and government leaders and focus on crucial  clinical, regulatory, financing and public policy issues.

5. One-on-One Dialogues Candid discussions between biopharma executives and industry experts offer a chance to hear about recent company successes, innovative projects on the horizon, and where China’s healthcare and biopharma industry is heading in 2014 and beyond.

Significant Collaborations & Acquisitions Involving Chinese Companies (2011-2012)Suzhou Connect Biopharma In–Licenses Anti-Inflammatory Drugs from Arena (USA)

Lee’s Pharma In–Licenses Therapeutic Peptide from RegeneRx (USA)

Ascletis In-Licenses Cancer RNAi Drug from Alnylam (USA)

Xiangxue Pharma In-Licenses Cancer Drug from Kinex Pharma (USA)

Ascepion Out-Licenses Cancer Drug Candidate to Debiopharm (Switzerland)

Zhifei Biological Expands Vaccine Partnership with Merck (USA)

Zhejiang Conba Pharma In-Licenses EVT 401 to Evotec (Europe)

Hua Medicine to Develop First Chinese-Tailored Diabetes Drug from Roche (Switzerland)

Simcere in Partnership to Develop Cardiovascular Compound with BMS (USA)

Fosun Pharma and Lonza (Switzerland) to Start Generic Drug JV

Representative Breakdown of Attendees by Geography

Europe: 33%USA: 27%China: 25%Asia: 15%

Representative Breakdown by Company Type

Biotech: 33%Pharma: 30%CMO/CRO: 14%Academic/Tech Transfer: 6%Services: 6%Govt/Econ Dev: 5%Bank/Investor: 4%Other: 2%

*Invited

CONfERENCE CO-HOSTED BY: EXHIBITION MANAGEMENT:

November 11-13, 2013 • China National Convention Center, Beijing, China

China’s Innovation Gets a Global Look.

AttendeesPast Western participants of the BIO® Convention in China include:

Abbott Acorda Therapeutics Inc. Aegis Capital Corp.AmgenAstraZenecaBaxterBioAtla LLC Biogen Idec Inc. Boehringer IngelheimBristol Myers-SquibbCatalent Pharma Solutions Celgene CorporationCeltaxsys Inc. CitigroupDelcath Systems Inc. Dicerna Pharmaceuticals Inc. Dykema Gossett PLLCEGEN Inc.Eli Lilly & Co Epitomics Inc.

Ernst & Young Euclid SystemsFountain Medical Development Corp Frontier Biosciences Inc. Goldman Sachs Henlius Biopharmaceuticals Inc.Johnson & JohnsonLadas & Perry LLPLeerink SwannMerck & Co Inc. Neurotech USA Inc. NovaMed Pharmaceutical CoOncoMed Pharmaceuticals Inc.Phage Pharmaceuticals Inc.Presidio Pharmaceuticals Inc. RocheSanofiSciClone Pharmaceuticals Inc. Synergion Biotechnologies Inc.

ExhibitionThe BIO® Convention in China features a high visibility exhibition area where attendees can view the most important technological advancements in biopharma from all over the world. Showcase your innovations and services alongside the best in biotech.

• Expanded exhibitor pavilion will feature 100 organizations

• Complimentary access to exhibition floor

• Breaks and networking receptions held in the exhibition pavilion each day

• Program agenda allows time between sessions to meet with exhibitors

Sponsors

Conference co-hosted by:The Biotechnology Industry Organization (BIO), the world’s largest biotechnology trade association, represents more than 1,100 biotechnology companies, academic institutions,

state biotechnology centers and related organizations across the United States and in more than 30 other nations.

The China Center for Pharmaceutical International Exchange (CCPIE), an independent, public institution affiliated with the China Food and Drug Administration (CFDA), includes the following departments: Division of General Affairs; Division

of Technological Cooperation; Division of Consultancy Services and Division of Conference & Exhibition.

®

METRIX

INTELEX

A A NM E R I CE T SL EME N

The World’s Manufacturer of Engineered and Advanced Materials

®

中国医药企业管理协会Chinese PharmaceuticalEnterprises Association

THE TRUSTED DAILY BIOPHARMACEUTICAL NEWS SOURCECONCISE, ACTIONABLE INSIGHT